On September 3, 2026, the FDA acknowledged reports of people having difficulty finding their usual estradiol transdermal patches. The agency said availability could vary by product, pharmacy and location, and described work with manufacturers to increase supply.

That is more specific than saying every patch is unavailable. If your refill is delayed, contact the pharmacist and prescriber early. Do not change patch strength, frequency or route on your own.

First, identify the actual supply problem

Ask the pharmacist whether the issue is your usual brand, a particular strength, the store’s wholesaler or a broader supply constraint. Have the exact prescription information available. A familiar box may be unavailable while another appropriate product can be discussed.

The FDA advises that a pharmacist may be able to locate another approved estradiol patch that can be substituted when appropriate. Whether substitution is possible depends on the prescription and product. Let the pharmacist and clinician handle that decision rather than comparing package numbers yourself.

Talk about alternatives before you run out

If a suitable patch cannot be found, the prescriber can discuss another estrogen product or a different plan. Pills, gels and sprays have different instructions and are not one-to-one replacements for patch strengths. Any companion progestogen regimen may also need to be considered.

Read patch versus pill to prepare for the conversation, but do not use an online chart to calculate a new dose. If you are traveling, mention the dates so refill timing and local availability can be addressed.

Compounding is not an automatic substitution

A supply difficulty does not establish that a particular compounded cream is equivalent to your approved patch. Ask what approved alternatives are available and, if compounding is proposed, why it is appropriate for your circumstances. The preparation’s absorption and quality need their own discussion.

The compounding guide explains the regulatory distinction. A pharmacy or clinic’s ability to supply a product does not by itself show that it is the best clinical alternative.

Check the financial effect

A changed brand, pharmacy or formulation may change your insurance coverage and out-of-pocket cost. Ask for the new price and quantity before the prescription is dispensed. If you receive medicine through a subscription, confirm whether a delayed shipment will still be billed and how a temporary alternative affects renewal.

The cost guide separates appointment, medication and subscription charges. Keep a record of the original order and any revised plan so you can follow the correct instructions.

What our update can and cannot confirm

We verified the FDA’s September notice; we did not check live stock at individual pharmacies. Availability can change much faster than an article. Provider pages may list a medicine even when a specific formulation is delayed.

If you use a home-delivery clinic such as Alloy, ask how it communicates stock problems and coordinates a safe alternative. If symptoms return during a gap, contact the prescriber rather than doubling the next dose or borrowing another person’s medicine.

FOLLOW THE EVIDENCE

Sources & further reading

Provider pages support service and price descriptions. Medical guidance supports treatment explanations. Neither is a first-hand review of patient outcomes. Checked September 20, 2026.

  1. FDA: September 2026 estradiol patch availability update
  2. FDA: understanding the risks of compounded drugs
  3. The Menopause Society: hormone therapy
This is educational information, not a diagnosis or a treatment plan. A licensed clinician should assess your medical history and any proposed prescription. For a medical emergency, call 911.